# Laguna Biotherapeutics Inc. — Form D

Laguna Biotherapeutics Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-28. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2022-10-28
- Form: D
- Accession: 0001952403-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 2
- Date of first sale: 2022-09-13
- Revenue range: Decline to Disclose
- SEC file number: 021-463089

## Issuer

- Name: Laguna Biotherapeutics Inc.
- CIK: 0001952403
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2315 6TH STREET, BERKELEY, CA, 94710
- Phone: (814) 880-6495

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Russell Carrington | Director | Berkeley, CA |
| Jonathan Kotula | Director | Berkeley, CA |
| Daniel Portnoy | Director | Berkeley, CA |
| Russell Carrington | Executive Officer | Berkeley, CA |
| Jonathan Kotula | Executive Officer | Berkeley, CA |

## More

- [CIK 1952403 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1952403&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001952403-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.